• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病患者中抗补体C1q自身抗体:与血管受累的关联

Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.

作者信息

Bassyouni Iman H, Gamal Sherif, Talaat Roba M, Siam Ibrahem

机构信息

Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, El-Kasr El-Aini Hospital, Cairo, Egypt,

出版信息

Mod Rheumatol. 2013 Apr 7. doi: 10.1007/s10165-013-0880-5.

DOI:10.1007/s10165-013-0880-5
PMID:23564409
Abstract

AIM

The aim of our study was to determine the prevalence of anti-C1q antibodies and their possible association with clinical presentation in Behcet's disease (BD) patients with special emphasis for patients with vascular involvement. METHODS: Plasma anti-C1q Abs levels were measured using an enzyme-linked immunosorbent assay in 51 BD patients and 25 age- and gender-matched healthy controls. RESULTS: We found elevated concentrations of anti-C1q more frequently in patients with BD (18 %) than in healthy controls (8 %). The highest prevalence was found in patients with vascular BD (42 %) which was significantly higher than patients without vascular BD and healthy controls (p = 0.025). Furthermore, patients with vascular BD had the highest mean anti-C1q levels when compared to BD patients without vascular involvement or healthy control subjects (p = 0.015). We did not find significant differences in the prevalence of any other organ involvement between BD patients with elevated vs. normal anti-C1q ab levels. Anti-C1q ab levels positively correlated with ESR (r = 0.383, p = 0.006) and negatively with C4 (r = -0.304, p = 0.030). CONCLUSION: In conclusion, we found an increased prevalence of anti-C1q autoantibodies in BD patients with vascular involvement. Further large scale longitudinal studies are required to assess and clarify the significance and the pathogenic role of anti-C1q antibodies in BD and other autoimmune diseases in which vasculitis is a component.

摘要

目的

我们研究的目的是确定抗C1q抗体的患病率及其与白塞病(BD)患者临床表现的可能关联,特别关注血管受累的患者。方法:采用酶联免疫吸附测定法测量51例BD患者和25例年龄及性别匹配的健康对照者的血浆抗C1q抗体水平。结果:我们发现BD患者中抗C1q浓度升高的频率(18%)高于健康对照者(8%)。血管性BD患者的患病率最高(42%),显著高于无血管性BD的患者和健康对照者(p = 0.025)。此外,与无血管受累的BD患者或健康对照者相比,血管性BD患者的平均抗C1q水平最高(p = 0.015)。我们未发现抗C1q抗体水平升高与正常的BD患者在其他任何器官受累患病率上有显著差异。抗C1q抗体水平与红细胞沉降率呈正相关(r = 0.383,p = 0.006),与C4呈负相关(r = -0.304,p = 0.030)。结论:总之,我们发现血管受累的BD患者中抗C1q自身抗体的患病率增加。需要进一步进行大规模纵向研究,以评估和阐明抗C1q抗体在BD及其他以血管炎为组成部分的自身免疫性疾病中的意义和致病作用。

相似文献

1
Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.白塞病患者中抗补体C1q自身抗体:与血管受累的关联
Mod Rheumatol. 2013 Apr 7. doi: 10.1007/s10165-013-0880-5.
2
Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.白塞病患者中抗补体C1q自身抗体:与血管受累的关联
Mod Rheumatol. 2014 Mar;24(2):316-20. doi: 10.3109/14397595.2013.854071.
3
Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.丙型肝炎病毒IV型慢性感染中的抗C1q:与自身免疫性风湿表现的关联
Immunol Invest. 2015;44(1):45-55. doi: 10.3109/08820139.2014.932378. Epub 2014 Jul 16.
4
Soluble levels of osteopontin in patients with Behcet's disease: association with disease activity and vascular involvement.白塞病患者骨桥蛋白的可溶性水平:与疾病活动和血管受累的关系。
J Clin Immunol. 2013 Feb;33(2):361-7. doi: 10.1007/s10875-012-9820-y. Epub 2012 Oct 25.
5
Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?白塞病患者血清基质金属蛋白酶-2和基质金属蛋白酶-9:其较高水平是否与伴有动脉瘤形成的血管性白塞病相关?
Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S70-5.
6
Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.系统性红斑狼疮患者中抗人纤连蛋白抗体的患病率及临床相关性研究。
Ann Rheum Dis. 1995 Feb;54(2):117-24. doi: 10.1136/ard.54.2.117.
7
Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions.抗C1q抗体在原发性和继发性血管炎病症中的临床应用价值。
Int J Health Sci (Qassim). 2017 Nov-Dec;11(5):3-6.
8
Clinical significance of Angiopoietin-1 in Behcet's disease patients with vascular involvement.血管生成素-1在伴有血管受累的白塞病患者中的临床意义。
Heart Vessels. 2016 Jun;31(6):918-24. doi: 10.1007/s00380-015-0686-9. Epub 2015 May 12.
9
Clinical significance of CCN2/connective tissue growth factor in Behçet's disease patients.CCN2/结缔组织生长因子在白塞病患者中的临床意义。
Int J Rheum Dis. 2019 Aug;22(8):1459-1465. doi: 10.1111/1756-185X.13597. Epub 2019 May 23.
10
Anti-cardiolipin and anti-Neutrophil Cytoplasmic Antibodies in Iranian patients with Behcet's disease.
Iran J Immunol. 2012 Dec;9(4):241-7.